- Home
- PLRX vs RDZN Comparison
PLRX vs RDZN Comparison
Compare PLRX & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- RDZN
- Stock Information
- Founded
- PLRX 2015
- RDZN 2015
- Country
- PLRX United States
- RDZN United States
- Employees
- PLRX N/A
- RDZN N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- PLRX Health Care
- RDZN Finance
- Exchange
- PLRX Nasdaq
- RDZN Nasdaq
- Market Cap
- PLRX 89.0M
- RDZN 77.5M
- IPO Year
- PLRX 2020
- RDZN N/A
- Fundamental
- Price
- PLRX $1.64
- RDZN $0.99
- Analyst Decision
- PLRX Hold
- RDZN Strong Buy
- Analyst Count
- PLRX 10
- RDZN 2
- Target Price
- PLRX $3.93
- RDZN $5.00
- AVG Volume (30 Days)
- PLRX 972.5K
- RDZN 295.6K
- Earning Date
- PLRX 08-07-2025
- RDZN 08-13-2025
- Dividend Yield
- PLRX N/A
- RDZN N/A
- EPS Growth
- PLRX N/A
- RDZN N/A
- EPS
- PLRX N/A
- RDZN N/A
- Revenue
- PLRX N/A
- RDZN $46,230,126.00
- Revenue This Year
- PLRX N/A
- RDZN $38.45
- Revenue Next Year
- PLRX N/A
- RDZN $66.38
- P/E Ratio
- PLRX N/A
- RDZN N/A
- Revenue Growth
- PLRX N/A
- RDZN N/A
- 52 Week Low
- PLRX $1.10
- RDZN $0.68
- 52 Week High
- PLRX $16.10
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- PLRX 56.62
- RDZN 43.12
- Support Level
- PLRX $1.40
- RDZN $0.96
- Resistance Level
- PLRX $1.70
- RDZN $1.07
- Average True Range (ATR)
- PLRX 0.11
- RDZN 0.08
- MACD
- PLRX 0.00
- RDZN -0.01
- Stochastic Oscillator
- PLRX 77.78
- RDZN 16.67
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.